Accelerating MedTech with Early Feasibility Studies (EFS)

Early Feasibility Studies (EFS) allow medical device developers to test new technologies in small patient groups, assessing safety, function, and design before larger trials. Conducting EFS for medical devices helps identify design improvements early, reduces development risks, and accelerates time to market. Regions like Latin America offer efficient regulatory pathways and diverse patient populations, enabling faster recruitment and high retention. With EFS, innovators can gather critical insights, optimize device performance, and enhance the success of subsequent trials, driving MedTech innovation more efficiently.